Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
Alexandros Sachinidis, Dragana Nikolić, Anca Pantea Stoian, Νικόλαος Παπάνας, Omer Tarar, Ali A. Rizvi, Manfredi Rizzo
Topics & Concepts
IncretinMedicineLixisenatideClinical trialGlucagon-like peptide-1Dipeptidyl peptidase-4Glucagon-like peptide 1 receptorPharmacologyClinical PracticeIntensive care medicineType 2 diabetesDiabetes mellitusLiraglutideBioinformaticsInternal medicineReceptorEndocrinologyBiologyAgonistFamily medicineDiabetes Treatment and ManagementPharmacology and Obesity TreatmentMetabolism, Diabetes, and Cancer